Literature DB >> 23696071

Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures.

Hacer Durmus1, Murat Kurtuncu, Erdem Tuzun, Munevver Pehlivan, Gulsen Akman-Demir, Zuhal Yapıcı, Mefkure Eraksoy.   

Abstract

Multiple sclerosis (MS) and epilepsy are common disorders, the co-occurrence of which has been of considerable interest. This study aimed to evaluate the prevalence and clinical features of epileptic seizures in patients with definite MS including those with pediatric onset (≤16 years of age). Out of 2,300 patients with definite MS followed in our outpatient clinic, 36 with epileptic seizures were identified. In this cohort, 8 out of 146 pediatric cases had seizures. The clinical and demographic features of the patients were recorded. Multiple logistic regression model with the occurence of seizures as the dependent variable was performed to identify the risk factors for seizure occurrence in MS patients. The prevalence of epileptic seizures was 1.5% in definite MS patients, 1.3% in adult-onset (comparable to seizure prevalence in the general population) and 5.5% in pediatric MS patients (≤16 years old). Twenty-six of 36 (72%) patients with MS and epilepsy developed recurrent seizures after the first epileptic seizure. Mean annual relapse rate (p ≤ 0.001), mean expanded disability status scale (EDSS) score (p = 0.004) and the ratio of patients with pediatric onset (p = 0.01) were higher in MS patients with seizures. In the multiple logistic regression analysis, age at MS onset and EDSS at the last examination were found to be predictors of seizure occurrence. Occurrence of seizures during the clinical course of MS appears to be associated with early-onset and increased disease severity and might be coincidental in adults.

Entities:  

Mesh:

Year:  2013        PMID: 23696071     DOI: 10.1007/s13760-013-0210-x

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  8 in total

1.  Effects of physical comorbidities on disability progression in multiple sclerosis.

Authors:  Tingting Zhang; Helen Tremlett; Feng Zhu; Elaine Kingwell; John D Fisk; Virender Bhan; Trudy Campbell; Karen Stadnyk; Robert Carruthers; Christina Wolfson; Sharon Warren; Ruth Ann Marrie
Journal:  Neurology       Date:  2018-01-03       Impact factor: 9.910

Review 2.  Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis.

Authors:  Sara Gasparini; Edoardo Ferlazzo; Michele Ascoli; Chiara Sueri; Vittoria Cianci; Concetta Russo; Laura Rosa Pisani; Pasquale Striano; Maurizio Elia; Ettore Beghi; Carmela Colica; Umberto Aguglia
Journal:  Neurol Sci       Date:  2017-01-04       Impact factor: 3.307

3.  Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center.

Authors:  Lisa Langenbruch; Julia Krämer; Sati Güler; Gabriel Möddel; Sophia Geßner; Nico Melzer; Christian E Elger; Heinz Wiendl; Thomas Budde; Sven G Meuth; Stjepana Kovac
Journal:  J Neurol       Date:  2019-05-08       Impact factor: 4.849

4.  Modulation of pacemaker channel function in a model of thalamocortical hyperexcitability by demyelination and cytokines.

Authors:  Rahul Chaudhary; Stefanie Albrecht; Maia Datunashvili; Manuela Cerina; Annika Lüttjohann; Ye Han; Venu Narayanan; Dane M Chetkovich; Tobias Ruck; Tanja Kuhlmann; Hans-Christian Pape; Sven G Meuth; Mehrnoush Zobeiri; Thomas Budde
Journal:  Cereb Cortex       Date:  2022-10-08       Impact factor: 4.861

Review 5.  A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Maria Trojano; Per Soelberg Sorensen; Gary Cutter; Stephen Reingold; Olaf Stuve
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

Review 6.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

7.  Recommendations for observational studies of comorbidity in multiple sclerosis.

Authors:  Ruth Ann Marrie; Aaron Miller; Maria Pia Sormani; Alan Thompson; Emmanuelle Waubant; Maria Trojano; Paul O'Connor; Kirsten Fiest; Nadia Reider; Stephen Reingold; Jeffrey A Cohen
Journal:  Neurology       Date:  2016-02-10       Impact factor: 9.910

Review 8.  Inhibiting Epileptiform Activity in Cognitive Disorders: Possibilities for a Novel Therapeutic Approach.

Authors:  Andras Attila Horvath; Emoke Anna Csernus; Sara Lality; Rafal M Kaminski; Anita Kamondi
Journal:  Front Neurosci       Date:  2020-10-15       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.